SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosis WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback